FLANIGANS ENTERPRISES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FLANIGANS ENTERPRISES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	104	107	113	116	113	137	158	174	187	205
Selling, general and administrative	18.3	18.7	19.9	20.8	19.9	20.3	26.6	4.68	5.31	5.46
Operating income	6.8	6.26	7.44	6.32	2.91	8.65	6.93	7.02	5.84	8.75
Interest expense	0.56	0.6	0.75	0.71	0.84	0.94	0.76	1.07	1.02	0.96
Other non-operating income	-0.47	-0.5	-0.68	-0.05	-0.79	9.3	2.88	-0.96	-0.26	-0.11
Pre-tax income	6.34	5.76	6.76	6.26	2.12	18	9.81	6.07	5.59	8.64
Income tax	1.37	1.37	1.37	0.89	-0.06	1.19	0.76	0.65	0.29	0.62
Net income to minority interests	1.93	1.37	1.71	1.73	1.07	4.98	2.74	1.42	1.94	2.98
Net income	3.04	3.02	3.68	3.65	1.11	11.8	6.31	4	3.36	5.03
EBITDA	9.37	8.8	10.1	9.24	6.06	11.6	6.96	7.05	5.87	13.4
EPS, basic	1.64	1.63	1.98	1.96	0.60	6.34	3.40	2.15	1.81	2.71
EPS, diluted	1.64	1.63	1.98	1.96	0.60	6.34	3.40	2.15	1.81	2.71
Shares, basic (weighted)	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86
Shares, diluted (weighted)	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86	1.86

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	10.2	9.89	13.4	13.7	29.9	32.7	42.1	25.5	21.4	20.1
Inventory	2.63	2.84	3.22	3.29	3.62	5.06	6.49	7.2	7.02	6.92
Other current assets										0.71
Total current assets	15.3	14.6	19	19.6	36.5	39.8	50.9	35.3	31.5	30.6
Property, plant and equipment	38.1	42.2	42.4	47.5	47	56.9	63.3	80.1	81.7	82.7
Lease right-of-use assets				27.8	22.2	28.6	29.5	27	26.8	24.8
Intangible assets	0.66	0.54	0.42	0.3	0.2	0.12	0.09	0.06	0.07	0.04
Other non-current assets	0.55	0.46	0.97	0.28	0.29	1.65	3.52	3.1	1.7	2.2
Total assets	56.4	60.5	67.3	68.8	112	128	147	146	142	141
Accounts payable	7.79	8.07	9.22	8.53	9.24	6.42	8.11	9.27	7.21	5.89
Deferred revenue							2.63	2.64	2.9	2.58
Short-term debt	1.47	1.08	1.96	1.98	5.09	2.56	2.3	1.3	1.4	1.48
Total current liabilities	11.5	11	13.3	13.1	25.4	20.2	22.2	22.4	19.9	18.1
Long-term debt	8.63	11.3	12.6	11.1	21.2	19.6	23.1	21.8	20.5	19.1
Lease liabilities					20.3	27.2	28.3	25.9	25.8	23.8
Total liabilities	20.1	22.3	25.9	24.2	66.9	67.4	74.2	70.9	66.7	61.5
Total debt	10.3	12.6	14.7	13.2	26.5	22.4	25.7	23.4	22.2	20.9
Paid-in capital	6.24	6.24	6.24	6.24	6.24	6.24	6.24	6.24	6.24	6.13
Retained earnings	28.8	31.4	34.6	37.7	38.8	50.6	55.1	58.2	60.7	64.7
Treasury stock	-6.08	-6.08	-6.08	-6.08	-6.08	-6.08	-6.08	-6.08	-6.08	-6.08
Other comprehensive income								0.4	-0.04
Shareholders' equity	29.3	32	35.2	38.3	39.4	51.2	55.7	59.2	61.2	65.2
Minority interests	6.99	6.2	6.15	6.21	6.13	9.42	17.7	15.7	14.2	13.9
Total equity	36.3	38.2	41.3	44.5	45.6	60.6	73.3	74.9	75.4	79.1
Total liabilities and equity	56.4	60.5	67.3	68.8	112	128	147	146	142	141
Shares outstanding					1.86			1.86	1.86	1.86

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	4.97	4.39	5.39	5.38	2.18	16.8	9.05	5.42	5.3	8.02
Depreciation and amortization	2.56	2.55	2.68	2.92	3.14	2.98	0.03	0.02	0.03	4.67
Deferred income tax	0.04	-0.06	0.69	0.36	-0.1	0.76	0.2	0.06	-0.27	-0.02
Change in inventory	-0.22	-0.21	-0.38	-0.22	-0.33	-1.44	-1.43	-0.71	0.18	0.1
Change in payables	0.5	0.28	0.26	-0.96	0.59	0.22	0.9	-0.06	-2.07	-1.01
Cash from operations	8.77	8.25	9.96	9.63	8.79	14	10.5	8.49	6.63	10.5
Capital expenditures	-3.07	-4.29	-2.8	-4.28	-2.26	-6.52	-4.02	-13.2	-3.45	-5.83
Acquisitions			-0	-0			-0.08
Cash from investing	-3.37	-7.05	-5.21	-4.61	-3.27	-11.6	-9.54	-18.6	-5.14	-6.12
Debt issued		2.92	3.5	0.25	4.4	2.76	8.71
Debt repaid	-2.04	-1.79	-2.5	-2.82	-2.54	-4.1	-3.74	-2.3	-1.25	-1.33
Dividends paid	-0.34	-0.37	-0.47	-0.52			-1.86	-0.84	-0.93	-1.02
Cash from financing	-4.49	-1.49	-1.22	-4.76	10.7	0.29	8.5	-6.54	-5.62	-5.7
Net change in cash	0.91	-0.29	3.53	0.26	16.3	2.75	9.46	-16.6	-4.13	-1.31
Free cash flow	5.69	3.97	7.16	5.34	6.53	7.5	6.49	-4.69	3.19	4.68
Interest paid	0.56	0.6	0.75	0.71	0.84	0.94	0.76	1.07	0.97	0.9
Income taxes paid	1.66	1.15	0.88	0.32	0.06	0.37	0.66	0.57	0.5	0.55

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $45.12 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	5.3%	Operating income / revenue.
Net margin	3.1%	Net income / revenue.
Return on equity (ROE)	9.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.2%	Net income / average total assets.
Return on invested capital (ROIC)	12.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	49.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	8.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	24.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	128.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	24.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	50.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-7.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	35.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	49.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-7.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	35.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	58.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	0.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	46.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-10.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-6.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	10.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	4.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.04x	Current assets / current liabilities.
Quick ratio	1.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.46x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.45x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	20.0%	Total debt / total assets.
Liabilities / assets	46.5%	Total liabilities / total assets.
Net debt	$2.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$20.5M	Current assets - current liabilities.
Tangible book value	$69.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.37x	Revenue / average total assets.
Fixed asset turnover	2.39x	Revenue / average property, plant and equipment.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.57	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$115.83	Revenue / diluted weighted shares.
Book value per share	$37.53	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$37.53	Tangible book value / shares outstanding.
Cash per share	$15.52	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$83.9M	Share price x shares outstanding.
Enterprise value	$86.5M	Market cap + total debt - cash - short-term investments.
P/E	12.6x	Market cap / net income. Only when net income is positive.
P/S	0.39x	Market cap / revenue.
P/B	1.20x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.20x	Market cap / tangible book value, when positive.
EV/Sales	0.40x	Enterprise value / revenue.
EV/EBIT	7.54x	Enterprise value / operating income, when both are positive.
Earnings yield	7.9%	Net income / market cap (the inverse of P/E).

What was FLANIGANS ENTERPRISES INC's revenue in fiscal 2025?

FLANIGANS ENTERPRISES INC reported revenue of $205.2M for fiscal 2025, 9.6% higher than the year before.

Was FLANIGANS ENTERPRISES INC profitable in fiscal 2025?

Yes. Net income was $5.0M, a net margin of 2.5%.

How much free cash flow did FLANIGANS ENTERPRISES INC generate in fiscal 2025?

Cash from operations of $10.5M minus capital expenditures of $5.8M left free cash flow of $4.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FLANIGANS ENTERPRISES INC